Cargando…
HIV-1 restriction by SERINC5
Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Δ Nef). SER5 inco...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085909/ https://www.ncbi.nlm.nih.gov/pubmed/35333966 http://dx.doi.org/10.1007/s00430-022-00732-x |
_version_ | 1785022029356859392 |
---|---|
author | Cano-Ortiz, Lucía Luedde, Tom Münk, Carsten |
author_facet | Cano-Ortiz, Lucía Luedde, Tom Münk, Carsten |
author_sort | Cano-Ortiz, Lucía |
collection | PubMed |
description | Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Δ Nef). SER5 incorporated into the viral membrane impairs the entry of HIV-1 by disrupting the fusion between the viral and the plasma membrane after envelope receptor interaction induced the first steps of the fusion process. The mechanisms of how SER5 prevents membrane fusion are not fully understood and viral envelope proteins were identified that escape the SER5-mediated restriction. Primate lentiviruses, such as HIV-1 and simian immunodeficiency viruses (SIVs), use their accessory protein Nef to downregulate SER5 from the plasma membrane by inducing an endocytic pathway. In addition to being directly antiviral, recent data suggest that SER5 is an important adapter protein in innate signaling pathways leading to the induction of inflammatory cytokines. This review discusses the current knowledge about HIV-1 restriction by SER5. |
format | Online Article Text |
id | pubmed-10085909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-100859092023-04-12 HIV-1 restriction by SERINC5 Cano-Ortiz, Lucía Luedde, Tom Münk, Carsten Med Microbiol Immunol Review Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Δ Nef). SER5 incorporated into the viral membrane impairs the entry of HIV-1 by disrupting the fusion between the viral and the plasma membrane after envelope receptor interaction induced the first steps of the fusion process. The mechanisms of how SER5 prevents membrane fusion are not fully understood and viral envelope proteins were identified that escape the SER5-mediated restriction. Primate lentiviruses, such as HIV-1 and simian immunodeficiency viruses (SIVs), use their accessory protein Nef to downregulate SER5 from the plasma membrane by inducing an endocytic pathway. In addition to being directly antiviral, recent data suggest that SER5 is an important adapter protein in innate signaling pathways leading to the induction of inflammatory cytokines. This review discusses the current knowledge about HIV-1 restriction by SER5. Springer Berlin Heidelberg 2022-03-25 2023 /pmc/articles/PMC10085909/ /pubmed/35333966 http://dx.doi.org/10.1007/s00430-022-00732-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Cano-Ortiz, Lucía Luedde, Tom Münk, Carsten HIV-1 restriction by SERINC5 |
title | HIV-1 restriction by SERINC5 |
title_full | HIV-1 restriction by SERINC5 |
title_fullStr | HIV-1 restriction by SERINC5 |
title_full_unstemmed | HIV-1 restriction by SERINC5 |
title_short | HIV-1 restriction by SERINC5 |
title_sort | hiv-1 restriction by serinc5 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085909/ https://www.ncbi.nlm.nih.gov/pubmed/35333966 http://dx.doi.org/10.1007/s00430-022-00732-x |
work_keys_str_mv | AT canoortizlucia hiv1restrictionbyserinc5 AT lueddetom hiv1restrictionbyserinc5 AT munkcarsten hiv1restrictionbyserinc5 |